Type 2 Diabetes Mellitus
Conditions
Interventions
1. Participants will be randomly and equally assigned into the test and placebo groups considering age, gender. 2.They will receive either one capsule of 20mg elemental Zinc or an identical placebo da
Sponsors
National Science Foundation
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18 years – 60 years 2. Fasting Blood Glucose (FBG) between 110-125mg/dl or 2-hr Post Oral Glucose Blood Glucose (OGTT) between 140-199mg/dl or both
Exclusion criteria
Exclusion criteria: 1. Patients on any vitamin or mineral supplementation 2.Current use of a weight loss medicine or dietary modification. 3. Alcohol consumption > 20 g/day 4.Lactation, pregnancy or unwillingness to use an effective form of birth control for women of child bearing years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of glycaemic control by Zinc supplementation using the following parameters: 1.Fasting Blood Glucose 2. Post Oral Glucose Blood Glucose 3. HbA1C 4. Serum Insulin [At baseline, 1, 3, 6 and 12 months] | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profile [At baseline, 1, 3, 6 and 12 months] Anthropometric assessment [At baseline, 1, 3, 6 and 12 months] Insulin resistance (using HOMA: Homeostatic Model Assessment of Insulin Resistance) [At baseline, 1, 3, 6 and 12 months ] | — |
Countries
Sri Lanka
Contacts
Public ContactDr Priyanga Ranasinghe ,
Lecturer
Outcome results
None listed